𝔖 Bobbio Scriptorium
✦   LIBER   ✦

AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With Schizophrenia

✍ Scribed by L. Degli Esposti; D. Sangiorgi; S. Buda


Book ID
119309833
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
122 KB
Volume
14
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Switching stable patients with schizophr
✍ Chris Hawley; Martin Turner; Muhammud A Latif; Vivienne Curtis; Packeruther T Sa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Abstract ## Objective An international, non‐randomised study evaluated efficacy and safety of risperidone long‐acting injectable (RLAI) compared to previous treatment. To investigate generisability of the European data set to the UK subset safety and switching data are reported here. ## Method

Effects of switching to long-acting inje
✍ Sung-Wan Kim; Il-Seon Shin; Jae-Min Kim; Seung-Hyun Lee; Yo-Han Lee; Su-Jin Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to long‐acting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirty‐six patients with schizophrenia treated with oral

Switching stable patients with schizophr
✍ Keith Lloyd; Muhammud A. Latif; Steve Simpson; Keshar L. Shrestha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective This international, non‐randomised study evaluated maintained efficacy and safety of Risperidone Long‐Acting Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e